| 2 Kingdom Street | Phone: +44-20-7604-8000 |
| London | Fax: +44-20-7604-8151 |
| W2 6BD | |
| United Kingdom | 
Map This Company |
AstraZeneca PLC Rankings
 #111 in FT Global 500 (June 2011) | FTSE 100 | STOXX Europe 50 |
Company Description
AstraZeneca's products run the gamut from A (top-selling breast cancer drug Arimidex) to Z (migraine treatment Zomig). One of the world's major pharmaceutical firms, AstraZeneca specializes in drugs for gastrointestinal, cardiovascular, neurology, respiratory, infection, and oncology therapeutic areas. The firm's biggest seller is acid reflux remedy Nexium. For matters of the heart, AstraZeneca makes hypertension and heart failure drug Atacand and cholesterol reducer Crestor. The company's other top drugs include anti-psychotic Seroquel, as well as Symbicort and Pulmicort for asthma. AstraZeneca also markets FluMist, a nasal influenza vaccine. The company's drugs are sold in more than 100 countries.
AstraZeneca PLC Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - London: AZN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 61,000 |
Executives
39 executives listed for AstraZeneca PLC's London, United Kingdom location.
| Chairman | Louis Schweitzer | |
|---|---|---|
| CEO and Director | David Brennan | |
| EVP Operations | David Smith |